Implants News and Research

RSS

Sorin Group to distribute CardioMedical's entire Cardio Vision MIS Portfolio

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today that it has entered into a distribution agreement, effective May 1, 2010, with CardioMedical GmbH, making Sorin Group, CardioMedical's selected partner for the entire Cardio Vision™ MIS Portfolio which is a comprehensive catalogue of minimally invasive cardiac surgery instruments and accessories.

3 May 2010

Interim study results demonstrate anti-tumor activity of CytRx's INNO-206 in myeloma tumor cells

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced interim study results that showed its doxorubicin prodrug INNO-206 demonstrated statistically significant anti-tumor activity in human myeloma tumor cells growing in immune-deficient mice compared to a control group, while exhibiting significantly less toxicity than doxorubicin even though INNO-206 was administered at much higher doses.

3 May 2010

Study could provide new strategies to prevent hospital-acquired infections

A bacterial pathogen can communicate with yeast to block the development of drug-resistant yeast infections, say Irish scientists writing in the May issue of Microbiology. The research could be a step towards new strategies to prevent hospital-acquired infections associated with medical implants.

3 May 2010

DENTSPLY International reports 7.7% increase in first-quarter 2010 net sales

DENTSPLY International Inc. today announced sales and earnings for the three months ended March 31, 2010. Net sales in the first quarter of 2010 increased 7.7% to $545.9 million compared to $506.9 million reported for the first quarter of 2009.

29 Apr 2010

RTI Biologics reports revenues of $37.8M for first-quarter 2010

RTI Biologics Inc., a leading processor of orthopedic and other biologic implants, reported operating results for the first quarter ending March 31, 2010

29 Apr 2010

SurModics reports second-quarter GAAP revenue of $18.4 million, up 6% sequentially

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, today reported financial results for the second quarter ended March 31, 2010.

29 Apr 2010

AAP testimony asks CDC DOH to include periodontal surveillance as part of strategic priorities

The American Academy of Periodontology was recently invited to provide testimony to the Centers for Disease Control and Prevention's Division of Oral Health as part of the strategic planning process for 2011 through 2014.

28 Apr 2010

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.

28 Apr 2010

SI-BONE to present iFuse MIS procedure at WCMISST 2010

SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint today announced that iFuse initial post-market clinical experience will be presented at upcoming 2010 minimally invasive spine surgery meetings.

28 Apr 2010

DRCR Network study finds new treatment more effective

28 Apr 2010

Better vision ahead for many diabetic retinopathy patients

A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.

27 Apr 2010

LCT receives grant of $500,000 for Phase II clinical trial of DIABECELL in New Zealand

Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.

27 Apr 2010

As hip replacement steadily increasing, patients need to know the facts before procedure: Surgeons

On the golf course, in the garden, or at the shopping mall, most people want to stay active, regardless of age. As the number of Americans reaching their 60s grows daily, the demand for mobility-restoring procedures, such as hip replacement, is steadily increasing.

24 Apr 2010

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

24 Apr 2010

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Cardiola AG announced today that the Company's CE-Marked m.pulse® Muscular CounterPulsation ("MCP")-based system demonstrated "an immediate improvement of cardiac output with non-invasive means" in a patient population of advanced yet stable chronic heart failure. The effects could be shown in 22 patients over three consecutive days.

24 Apr 2010

UIC College of Dentistry awarded $10M federal grant to upgrade research facilities

The University of Illinois at Chicago College of Dentistry has received a $10 million federal grant to transform its research facilities into a state-of-the-art clinical and translational research center.

23 Apr 2010

Zimmer reports increase of 7.1% in net sales for first-quarter

Zimmer Holdings, Inc. today reported financial results for the quarter ended March 31, 2010. The Company reported first quarter net sales of $1.06 billion, an increase of 7.1% reported and 3.4% constant currency over the first quarter of 2009. Diluted earnings per share for the quarter were $1.01 reported and $1.02 adjusted, an increase of 7.4% adjusted over the prior year period.

22 Apr 2010

Cook Medical enrolls first patient in Formula PTX Balloon Expandable Renal Stent trial

Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.

22 Apr 2010

Receiving cochlear implant before 18 months of age improves child's ability to hear: Study

Receiving a cochlear implant before 18 months of age dramatically improves a deaf child's ability to hear, understand and, eventually, speak, according to a multicenter study led by scientists at Johns Hopkins.

21 Apr 2010

LDR completes IDE study on Mobi-C cervical artificial disc

LDR, a privately held company with innovative spinal implants for non-fusion and fusion applications, announced completion of the 24-month follow-up phase of its two-level IDE study on the Mobi-C cervical artificial disc. Having previously finalized the 24-month follow-up phase of the one-level study earlier this year, LDR is now the first company to fully enroll and reach two-year follow-up on a concurrent one-level and two-level cervical artificial disc replacement study.

21 Apr 2010

Implants News and Research

Sorin Group to distribute CardioMedical's entire Cardio Vision MIS Portfolio

Interim study results demonstrate anti-tumor activity of CytRx's INNO-206 in myeloma tumor cells

Study could provide new strategies to prevent hospital-acquired infections

DENTSPLY International reports 7.7% increase in first-quarter 2010 net sales

RTI Biologics reports revenues of $37.8M for first-quarter 2010

SurModics reports second-quarter GAAP revenue of $18.4 million, up 6% sequentially

AAP testimony asks CDC DOH to include periodontal surveillance as part of strategic priorities

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

SI-BONE to present iFuse MIS procedure at WCMISST 2010

DRCR Network study finds new treatment more effective

Better vision ahead for many diabetic retinopathy patients

LCT receives grant of $500,000 for Phase II clinical trial of DIABECELL in New Zealand

As hip replacement steadily increasing, patients need to know the facts before procedure: Surgeons

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

UIC College of Dentistry awarded $10M federal grant to upgrade research facilities

Zimmer reports increase of 7.1% in net sales for first-quarter

Cook Medical enrolls first patient in Formula PTX Balloon Expandable Renal Stent trial

Receiving cochlear implant before 18 months of age improves child's ability to hear: Study

LDR completes IDE study on Mobi-C cervical artificial disc

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News